Cruz announces that investors with losses related to Telix Pharmaceuticals Limited ("Telix" or the "Company") (NASDAQ: TLX) have opportunity to lead the securities fraud class action lawsuit. IF YOU ...

Wilson Encourages Investors Who Suffered Losses in Telix to Contact Him Directly to Discuss Their OptionsIf you purchased or acquired ...

National shareholder rights law firm Hagens Berman is issuing a reminder to investors in Telix Pharmaceuticals Ltd. (NASDAQ: ...

National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Telix Pharmaceuticals ...

Partner Reed Kathrein Scrutinizing Alleged Misstatements on Prostate Cancer Drug TLX591 Progress and Third-Party ManufacturingSAN FRANCISCO, Dec. 27, 2025 /PRNewswire/ -- National shareholder rights ...

Detailed price information for Telix Pharmaceutical Ltd (TLPPF) from The Globe and Mail including charting and trades.

This article examines whether Telix Pharmaceuticals is a beaten down opportunity or a value trap at current levels, and explores what the market might be missing in the share price. Despite being down ...

For example, here are three ASX stocks that could potentially double in 2026 if everything goes to plan.

Telix Pharmaceuticals leverages a novel theranostic approach, offering a unique risk-reward model in the challenging biotech climate, focusing on targeted radiation therapy. Strong revenue momentum ...

Telix Pharmaceuticals Ltd. (TLPPF – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Tara Bancroft from TD Cowen maintained a Buy rating on ...

Telix Pharmaceuticals Ltd (NASDAQ:TLX) is the world's most "diversified, comprehensively positioned, and standalone publicly-traded radiopharmaceuticals company," according to HC Wainwright. The Telix ...

Telix Pharmaceuticals Limited (NASDAQ:TLX) on Tuesday released preliminary results from the Phase 2 IPAX-Linz study of TLX101 (131I-iodofalan1) in recurrent high-grade glioma (brain cancer), ...